X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2227) 2227
Book Review (362) 362
Newsletter (95) 95
Publication (67) 67
Book Chapter (53) 53
Newspaper Article (36) 36
Magazine Article (35) 35
Book / eBook (19) 19
Trade Publication Article (10) 10
Report (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1653) 1653
humans (1652) 1652
insulin (1241) 1241
male (919) 919
female (914) 914
diabetes (800) 800
insulin - therapeutic use (697) 697
diabetes mellitus, type 2 - drug therapy (679) 679
hypoglycemic agents - therapeutic use (670) 670
endocrinology & metabolism (663) 663
middle aged (627) 627
adult (593) 593
insulin - administration & dosage (571) 571
diabetes mellitus, type 1 - drug therapy (515) 515
insulin - analogs & derivatives (509) 509
insulin, isophane - therapeutic use (488) 488
hypoglycemic agents - administration & dosage (477) 477
blood glucose - metabolism (427) 427
type 2 diabetes (422) 422
aged (394) 394
hypoglycemia (371) 371
insulin, isophane - administration & dosage (352) 352
insulin glargine (324) 324
hypoglycemic agents - adverse effects (315) 315
therapy (312) 312
glucose (298) 298
diabetes mellitus (280) 280
insulin - adverse effects (279) 279
insulin, long-acting (273) 273
glycemic control (269) 269
diabetes therapy (264) 264
drug administration schedule (263) 263
diabetes mellitus, type 2 - blood (262) 262
mellitus (260) 260
animals (259) 259
treatment outcome (258) 258
care and treatment (247) 247
diabetes mellitus, type 1 - blood (237) 237
nph insulin (237) 237
medicine, general & internal (231) 231
abridged index medicus (230) 230
adolescent (225) 225
diabetes mellitus - drug therapy (221) 221
type 1 diabetes (218) 218
blood glucose - analysis (217) 217
insulin, isophane (210) 210
hypoglycemia - chemically induced (209) 209
glycated hemoglobin a - metabolism (206) 206
blood glucose - drug effects (205) 205
drug therapy (198) 198
internal medicine (195) 195
insulin, isophane - adverse effects (193) 193
research (193) 193
medicine & public health (187) 187
hyperglycemia (182) 182
pharmacology & pharmacy (172) 172
glycated hemoglobin a - analysis (170) 170
drug therapy, combination (168) 168
glargine (165) 165
risk factors (158) 158
insulin aspart (154) 154
insulin detemir (154) 154
dosage and administration (152) 152
time factors (149) 149
insulin - blood (145) 145
management (145) 145
child (144) 144
basal insulin (141) 141
injections, subcutaneous (133) 133
insulin, long-acting - therapeutic use (130) 130
health aspects (125) 125
complications (123) 123
analysis (121) 121
biphasic insulins (115) 115
hypoglycemia - prevention & control (114) 114
insulin, long-acting - administration & dosage (114) 114
risk (114) 114
blood sugar (111) 111
dose-response relationship, drug (111) 111
diabetics (110) 110
insulin lispro (107) 107
insulin resistance (107) 107
retrospective studies (104) 104
insulin - pharmacology (103) 103
metformin (103) 103
insulin - pharmacokinetics (100) 100
type 2 diabetes mellitus (100) 100
hypoglycemia - epidemiology (97) 97
blood glucose (94) 94
clinical trials (93) 93
cross-over studies (93) 93
hypoglycaemia (93) 93
pregnancy (92) 92
prospective studies (91) 91
rats (89) 89
patients (88) 88
pharmacokinetics (87) 87
trial (87) 87
dextrose (86) 86
children (83) 83
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Baycrest Hospital - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2368) 2368
German (28) 28
French (14) 14
Spanish (10) 10
Swedish (7) 7
Chinese (6) 6
Czech (5) 5
Japanese (5) 5
Portuguese (5) 5
Dutch (3) 3
Finnish (2) 2
Hungarian (2) 2
Italian (2) 2
Polish (2) 2
Russian (2) 2
Serbian (2) 2
Danish (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 12/2015, Volume 17, Issue 12, pp. 1142 - 1149
Aims: To compare the efficacy and safety of new insulin glargine 300 U/ml (Gla-300) with insulin glargine 100 U/ml (Gla-100) over 12 months of treatment in... 
basal insulin | oral antihyperglycaemic drugs | type 2 diabetes | insulin glargine | Type 2 diabetes | Basal insulin | Insulin glargine | Oral antihyperglycaemic drugs | NAIVE PATIENTS | ENDOCRINOLOGY & METABOLISM | TO-TARGET TRIAL | BEGIN | UNITS/ML | DEGLUDEC | Glycated Hemoglobin A - analysis | Hypoglycemia - epidemiology | Humans | Middle Aged | Risk | Patient Dropouts | Incidence | Patient Satisfaction | Hypoglycemia - prevention & control | Insulin Glargine - administration & dosage | Isophane Insulin, Human - administration & dosage | Hyperglycemia - chemically induced | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Drug Compounding | Weight Gain - drug effects | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Isophane Insulin, Human - therapeutic use | Insulin Glargine - adverse effects | Administration, Oral | Insulin Glargine - therapeutic use | Isophane Insulin, Human - adverse effects | Diabetes Mellitus, Type 2 - blood | Intention to Treat Analysis | Blood Glucose Self-Monitoring | Hyperglycemia - epidemiology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Hemoglobin | Glucose | Insulin | Dextrose | Diabetes therapy | Confidence intervals | Diabetes | Hypoglycemia | Index Medicus | Original
Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 4/2004, Volume 47, Issue 4, pp. 622 - 629
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2017, Volume 19, Issue 8, pp. 1116 - 1126
Aims: To compare glucose control and safety of different basal insulin therapies (BI, including Insulin NPH, glargine and detemir) in real-world clinical... 
basal insulin | glycaemic control | type 2 diabetes | RANDOMIZED CONTROLLED-TRIALS | PROPENSITY SCORE | TREATMENT ORBIT | TO-TARGET TRIAL | OBSERVATIONAL REGISTRY | ORAL ANTIHYPERGLYCEMIC DRUGS | NPH INSULIN | GLARGINE | ENDOCRINOLOGY & METABOLISM | CLINICAL-PRACTICE | TYPE-2 | Glycated Hemoglobin A - analysis | Prospective Studies | Humans | Insulin Detemir - therapeutic use | Dose-Response Relationship, Drug | Hypoglycemia - prevention & control | Insulin Glargine - administration & dosage | Drug Therapy, Combination - adverse effects | Insulin Detemir - administration & dosage | Hypoglycemic Agents - administration & dosage | Insulin Detemir - adverse effects | China | Hypoglycemia - physiopathology | Registries | Weight Gain - drug effects | Hypoglycemia - chemically induced | Drug Resistance | Hypoglycemic Agents - therapeutic use | Insulin, Isophane - administration & dosage | Severity of Illness Index | Hyperglycemia - prevention & control | Insulin Glargine - adverse effects | Lost to Follow-Up | Insulin Glargine - therapeutic use | Diabetes Mellitus, Type 2 - blood | Insulin, Isophane - therapeutic use | Insulin, Isophane - adverse effects | Intention to Treat Analysis | Diabetes Mellitus, Type 2 - drug therapy | Drug Monitoring | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Medical research | Glycosylated hemoglobin | Medicine, Experimental | Glucose | Comparative analysis | Insulin | Dextrose | Hypoglycemia | Diabetes | Index Medicus
Journal Article
Diabetic Medicine, ISSN 0742-3071, 04/2016, Volume 33, Issue 4, pp. 497 - 505
Insulin degludec/insulin aspart (IDegAsp) is the first soluble co‐formulation that combines two insulin analogues. It provides effective basal and prandial... 
TO-TARGET TRIAL | MELLITUS | INJECTION | ENDOCRINOLOGY & METABOLISM | BASAL | Glycated Hemoglobin A - analysis | Insulin Aspart - therapeutic use | Hypoglycemia - epidemiology | Biphasic Insulins - adverse effects | Humans | Middle Aged | Insulin, Long-Acting - chemistry | Male | Risk | Hypoglycemia - prevention & control | Insulin Aspart - administration & dosage | Hypoglycemic Agents - administration & dosage | Hypoglycemia - physiopathology | Female | Hypoglycemia - chemically induced | Meals | Hypoglycemic Agents - therapeutic use | Insulin, Isophane - administration & dosage | Severity of Illness Index | Hyperglycemia - prevention & control | Blood Glucose - analysis | Drug Administration Schedule | Solubility | Hypoglycemic Agents - chemistry | Insulin, Long-Acting - adverse effects | Diabetes Mellitus, Type 2 - blood | Insulin, Isophane - therapeutic use | Insulin, Long-Acting - administration & dosage | Biphasic Insulins - therapeutic use | Insulin, Isophane - adverse effects | Insulin, Long-Acting - therapeutic use | Blood Glucose Self-Monitoring | Aged | Biphasic Insulins - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Drug Monitoring | Hypoglycemic Agents - adverse effects | Insulin Aspart - adverse effects | Drug Combinations | Plasma | Fasting | Glucose | Diabetes | Hypoglycemia | Insulin | Index Medicus | Treatment | Research
Journal Article
Diabetes Care, ISSN 0149-5992, 2014, Volume 37, Issue 8, pp. 2084 - 2090
Journal Article